Monroe Capital announced it acted as sole lead arranger and administrative agent on the funding of a $30 million senior credit facility to support the growth of a diagnostic services company.

Based in the Southwest, the company provides specialized toxicology and pathology diagnostic lab testing services to clinical healthcare providers in the nature of urine drug monitoring for pain management, addiction medicine, and other outpatient screening compliance monitoring providers, and standardized gastrointestinal and dermatological lab testing services.